Vitafoods Europe

The company’s specialty technology enhanced the bioavailability of astaxanthin, according to a new clinical study.

At the new cultivation and production site, the ingredient will replace tobacco plants and be researched for its portfolio of bioactives.

The new concepts target unique health outcomes such as gut-brain axis improvements and overall microbiome balance.

The company will highlight several other botanical ingredients and its approach to the European market.

Breaking News

Latest

Subscribe to Magazine for top news, trends & analysis